Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical (2021)
- Authors:
- Autor USP: KLEINGESINDS, EDUARDO KREBS - FCF
- Unidade: FCF
- Sigla do Departamento: FBT
- DOI: 10.11606/T.9.2021.tde-21122021-144906
- Subjects: LEUCEMIA; BIOPROCESSOS; PROTEÍNAS RECOMBINANTES
- Keywords: Bioprocess; Bioprocesso; Co-cultura; Co-culture; Leucemia; Leukemia; Microambiente tumoral; Proteínas recombinantes; Recombinant proteins; Tumor microenvironment
- Agências de fomento:
- Language: Inglês
- Abstract: According to the World Health Organization (WHO), in 2020, 474 519 new cases of leukemia were reported around the world, and 311 594 new deaths were reported. The importance of L-asparaginase (LASNase) as a biopharmaceutical to treat Acute Lymphoblastic Leukemia (ALL) is recognized worldwide. This work describes the bioprocessing of L-ASNase from Erwinia chrysanthemi expressed extracellularly by Pichia pastoris with a human-like glycosylation pattern. Firstly, it was optimized the upstream conditions in the orbital shaker flask. Then, it was scaled up using a 3L benchtop bioreactor at batch mode under 35 °C and 1.5% methanol as an inductor for L-ASNase production. The downstream processing was evaluated using crossflow ultrafiltration with different cut-offs (10-100 kDa) followed by cation exchange chromatography and size exclusion chromatography. It was possible to reach a final yield of 54.93% with a purification factor of 70.93 fold and the proteomics data confirmed the attainment of an extremely pure enzyme. At pH 8.0 and 50 °C, the enzyme showed its optimum activity. Kinetic parameters, ‘k IND.M’ and ‘V IND.MAX’, were found to be 76.4 µM and 0.065 µmol ‘min POT.-1’, respectively. The thermodynamic study showed that the enzyme irreversible deactivation is well described by first-order kinetics. Finally, using a high throughput fluorescentbased in vitro experimental platform, it was investigated the concomitant impact of this recombinant L-ASNase on enhanced green fluorescent protein (eGFP)-labeled tumor cell lines (SEMK2, HB119, REH, and MV411) when co-cultured with the mCherry-labelled bone marrow fibroblastic stroma cells HS5. The outcomes of this research suggest that the eGFP-Hb11-9 strain was the most sensitive strain when treated with the glycosylated L-ASNase, in contrast with the eGFP-REH that was the most resistant linage. It was also observed lower effectiveness of thedrug when tumor cells were co-cultured with stromal cells than when tumor cells were cultured on their own. Hence, this work paves the way for production, scale-up, and pre-clinical trials of this promising novel biopharmaceutical, which may help improve the remission rates and quality of life for many cancer patients around the world
- Imprenta:
- Data da defesa: 03.12.2021
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
KLEINGESINDS, Eduardo Krebs. Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical. 2021. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/. Acesso em: 07 maio 2026. -
APA
Kleingesinds, E. K. (2021). Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/ -
NLM
Kleingesinds EK. Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical [Internet]. 2021 ;[citado 2026 maio 07 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/ -
Vancouver
Kleingesinds EK. Exploring the role of a glycosylated L-asparaginase expressed by a recombinant Pichia pastoris as an antileukemic biopharmaceutical [Internet]. 2021 ;[citado 2026 maio 07 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9134/tde-21122021-144906/ - Avaliação da hidrólise enzimática do sabugo de milho pré-tratado com ácido diluído e surfactante para a obtenção de bioetanol
- Laccases produced by Peniophora from marine and terrestrial origin: a comparative study
- An improved method for simple and accurate colorimetric determination of L-asparaginase enzyme activity using Nessler's reagent
- Intensification of bioethanol production by using Tween 80 to enhance dilute acid pretreatment and enzymatic saccharification of corncob
- Increased glycosylated L-asparaginase production through selection of Pichia pastoris platform and oxygen-methanol control in fed-batches
- Glycosylation of Erwinase results in active protein less recognized by antibodies
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
